Startseite › Eierstockkrebs › Washington › Seattle
Klinische Studien zu Eierstockkrebs in Seattle, WA
30 Studien zu Eierstockkrebs suchen Teilnehmer an Standorten in und um Seattle (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Teilnehmer gesuchtPhase 2
- Swedish Medical Center-First Hill, Seattle
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Teilnehmer gesuchtPhase 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
Teilnehmer gesucht
- University of Washington, Seattle
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Teilnehmer gesuchtBeobachtungsstudie
- Fred Hutchinson Cancer Center, Seattle
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Teilnehmer gesuchtPhase 1/2
- Seattle Cancer Care Alliance at South Lake Union - G3630, Seattle
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Teilnehmer gesuchtPhase 2
- Virginia Mason Hospital and Medical Center /ID# 277259, Seattle
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Teilnehmer gesuchtPhase 3
- Swedish Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
Teilnehmer gesuchtPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Teilnehmer gesuchtPhase 1
- University of Washington Fred Hutchinson, Seattle
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Teilnehmer gesuchtPhase 3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Teilnehmer gesuchtPhase 2
- Swedish Cancer Institute, Seattle
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Teilnehmer gesucht
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- und 3 weitere
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Teilnehmer gesuchtPhase 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- und 4 weitere
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Fred Hutchinson Cancer Center, Seattle
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Teilnehmer gesuchtPhase 1/2
- Swedish Cancer Institute, Seattle
Clinical Pre-screening Protocol for Ovarian Cancer
Teilnehmer gesuchtBeobachtungsstudie
- Swedish Center for Research and Innovation, Seattle
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Teilnehmer gesuchtPhase 2/3
- University of Washington - Seattle Cancer Care Alliance, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Teilnehmer gesuchtPhase 2
- University of Washington School of Medicine, Seattle
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Swedish Cancer Institute, Seattle
- Swedish Medical Center, Seattle
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
Teilnehmer gesuchtGesunde Freiwillige willkommen
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Teilnehmer gesuchtPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
Teilnehmer gesuchtBeobachtungsstudie
- Fred Hutch/University of Washington Cancer Consortium, Seattle
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Teilnehmer gesucht
- University of Washington, Seattle
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Teilnehmer gesuchtPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Teilnehmer gesuchtPhase 1
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Seattle
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Teilnehmer gesuchtBeobachtungsstudie
- The Swedish Hospital, Seattle
Eierstockkrebs-Studien in anderen Städten
- Houston, TX89 Studien
- New York City, NY69 Studien
- Boston, MA61 Studien
- Los Angeles, CA50 Studien
- Nashville, TN49 Studien
- Arlington, VA46 Studien
- Philadelphia, PA44 Studien
- Columbus, OH39 Studien
- St. Louis, MO38 Studien
- Chicago, IL36 Studien
- San Antonio, TX31 Studien
- Cleveland, OH30 Studien
Weitere Studien in Seattle
- Nichtkleinzelliges Lungenkarzinom53 Studien
- Krebs (alle Arten)49 Studien
- Prostatakrebs42 Studien
- Akute myeloische Leukämie40 Studien
- Brustkrebs39 Studien
- Metastasierender Krebs39 Studien
- Kolorektales Karzinom34 Studien
- Lungenkrebs33 Studien
- Multiples Myelom22 Studien
- Myelodysplastische Syndrome21 Studien
- Akute lymphoblastische Leukämie21 Studien
- Blasenkrebs21 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.